Elanco Animal Health Incorporated

NYSE:ELAN

Drug Manufacturers - Specialty & Generic

Healthcare
$26.70 -3.47%

-$0.84 today

Market cap
$13.35B
Beta
1.70
P/E (TTM)
-48.1
EPS (TTM)
-$0.49
52W Low $13.16High $27.72

Volume 5.78M

Average 6.04M

ELAN Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Elanco Animal Health IncorporatedNYSE: ELAN

Operating Margin · Q3 FY2026 · quarter ended Sep 2026

Operating margin widens to 6.4%

Operating margin was 6.4% in Q3 FY2026, up 4.0 pp from a year earlier. On a trailing-twelve-month basis it was 10.0%, up 4.8 pp year over year. Over 3 fiscal years it narrowed by 3.4 pp.

Context

  • Operating margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 9 analysts of 18.1% for the fiscal year ending Dec 2026, up from 5.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
6.4%-1.6 pp QoQ
Last fiscal yearDec 2025
5.3%-0.3 pp YoY
LTMSep 2026
10.0%+4.8 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.0 pp+11.4 pp+7.4 pp
1 year-0.3 pp+12.8 pp+13.1 pp
3 years-3.4 pp+13.8 pp+17.2 pp
5 years+14.4 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
5.3%
Year-over-year change
-0.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How ELAN compares with its peers on the latest reported figures

  • ELAN's LTM Sep 2026 operating margin of 10.0% is the 5th highest of the 6 companies compared; the peer median is 16.7%.
  • Its year-over-year change of +4.8 pp is the highest of 6, against a peer median of -0.5 pp.
  • Over three fiscal years its change of -3.4 pp compares with a peer median of +1.8 pp.
ELAN Competitors Peer median
Operating Margin for ELAN and competitors
Company Period LTM level YoY 3-year change
ZTSZoetis Inc.LTM Jun 202637.0% -0.5 pp+1.8 pp
IDXXIDEXX Laboratories, Inc.LTM Sep 202632.3% +1.0 pp+4.9 pp
MRKMerck & Co., Inc.LTM Jun 202616.7% -16.9 pp+5.3 pp
PAHCPhibro Animal Health CorporationLTM Mar 202612.3% +4.3 pp+0.1 pp
ELANElanco Animal Health IncorporatedLTM Sep 202610.0% +4.8 pp-3.4 pp
NEOGNeogen CorporationLTM Aug 2026-0.8% -0.8 pp-7.0 pp
Peer median (excluding ELAN) 16.7%-0.5 pp+1.8 pp

Competitors are the stored peer set for ELAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.76B4.41B4.42B4.44B4.72B
Cost of Revenue2.69B2.44B2.48B2.53B2.67B
Gross Profit2.08B1.97B1.94B1.91B2.05B
Gross Margin43.6%44.7%43.9%43.0%43.5%
Research & Development369M321M327M344M368M
Selling, General & Admin1.4B1.27B1.29B1.31B1.43B
Operating Expenses1.77B1.59B1.61B1.66B1.8B
Depreciation & Amortization716M682M694M662M680M
EBITDA409M866M(224M)1.49B676M
EBITDA Margin8.6%19.6%-5.1%33.5%14.3%
Operating Income304M384M326M251M252M
Operating Margin6.4%8.7%7.4%5.7%5.3%
Interest Income000045M
Interest Expense264M256M277M339M220M
Other Income / Expenses(875M)(456M)(1.52B)237M(476M)
Income Before Tax(571M)(72M)(1.2B)488M(224M)
Pre-Tax Margin-12.0%-1.6%-27.1%11.0%-4.8%
Income Tax Expense(88M)6M36M150M8M
Net Income(483M)(78M)(1.23B)338M(232M)
Net Margin-10.1%-1.8%-27.9%7.6%-4.9%
EPS (Basic)(0.97)(0.15)(2.50)0.68(0.47)
EPS (Diluted)(0.97)(0.15)(2.50)0.68(0.47)
Weighted Avg Shares487.2M488.3M492.3M494M496.4M
Weighted Avg Shares (Diluted)487.2M488.3M492.3M497.3M496.4M

Elanco Animal Health Incorporated

NYSE:ELAN

Intrinsic Alpha fair value

Locked

Current Price

$26.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.